Cargando…

Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells

INTRODUCTION: Pregnant women are exposed to various carcinogenic substances that can subsequently affect their progeny. Recurrent preleukemic chromosomal translocations characteristic for childhood acute lymphoblastic leukemia (ALL) frequently emerge before birth in utero. The most common translocat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhave, Rigveda, Kameri, Ersen, Körschgen, Lutz, Jepsen, Vera, Hecker, Katharina, Pandyra, Aleksandra, Borkhardt, Arndt, Fischer, Ute, Koegler, Gesine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476933/
http://dx.doi.org/10.1093/stcltm/szad047.025
_version_ 1785101038281293824
author Bhave, Rigveda
Kameri, Ersen
Körschgen, Lutz
Jepsen, Vera
Hecker, Katharina
Pandyra, Aleksandra
Borkhardt, Arndt
Fischer, Ute
Koegler, Gesine
author_facet Bhave, Rigveda
Kameri, Ersen
Körschgen, Lutz
Jepsen, Vera
Hecker, Katharina
Pandyra, Aleksandra
Borkhardt, Arndt
Fischer, Ute
Koegler, Gesine
author_sort Bhave, Rigveda
collection PubMed
description INTRODUCTION: Pregnant women are exposed to various carcinogenic substances that can subsequently affect their progeny. Recurrent preleukemic chromosomal translocations characteristic for childhood acute lymphoblastic leukemia (ALL) frequently emerge before birth in utero. The most common translocation t (12;21) occurs in 25% of B-cell precursor ALL and results in the formation of the chimeric oncogenic transcription factor ETV6::RUNX1. OBJECTIVES: We aim to analyze factors promoting the generation of preleukemic ETV6::RUNX1 translocations, investigate the biological origin of these preleukemic cells, and develop an in vitro model of early B-cell differentiation to analyze the mechanisms underlying the persistence of ETV6::RUNX1+ preleukemic cells and leukemia evolution in children. METHODS: Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL) (Schafer et. al., 2018) was applied to identify ETV6::RUNX1+ cord blood units (CBU). Screening results were validated by Sanger sequencing and quantified by real-time PCR (ipsogen ETV6-RUNX1 Kit, Qiagen). ETV6::RUNX1+ CBUs were thawed, sorted for CD34(+) and CD19(+) cells, and analyzed by qPCR. CD34(+) were differentiated towards B-cell lineage on MSC feeder lines according to a modified protocol (Ichii et. al., 2008). RESULTS: We screened a cohort of 1405 cord bloods collected in 2004 and discovered that 103 (7.3%) carried the ETV6::RUNX1 fusion gene. The preleukemic translocation was detected in CD34(+) stem and early B progenitor cells. For the establishment of an in vitro B-cell differentiation model, bone marrow (BM-MSCs) and CB (USSCs, CB-MSCs) stromal feeder cells were compared and the effect of different media (SCGM, DMEM/5 % FCS, MSCBM/10 % FCS) in the presence of stem cell factor (SCF), Flt-3, IL3, +/- IL7 was assessed. BM-MSCs demonstrated the highest ability to support B-lymphopoieses towards CD19(+) cell differentiation in MSCBM media (~30%), primarily due to the release of IL-7 by the feeder layer. Currently, factors that may promote generation of preleukemic translocations in utero e.g. nitrosamines contained in food products, are being tested in this model. DISCUSSION: We identified the HSC/early B progenitor state as the origin of ETV6::RUNX1 translocations in CB. The establishment of an in vitro B-cell differentiation system will allow to test the impact of environmental carcinogens on the generation of ETV6::RUNX1+ pre-leukemic cells and their leukemic evolution.
format Online
Article
Text
id pubmed-10476933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104769332023-09-05 Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells Bhave, Rigveda Kameri, Ersen Körschgen, Lutz Jepsen, Vera Hecker, Katharina Pandyra, Aleksandra Borkhardt, Arndt Fischer, Ute Koegler, Gesine Stem Cells Transl Med Preclinical Studies INTRODUCTION: Pregnant women are exposed to various carcinogenic substances that can subsequently affect their progeny. Recurrent preleukemic chromosomal translocations characteristic for childhood acute lymphoblastic leukemia (ALL) frequently emerge before birth in utero. The most common translocation t (12;21) occurs in 25% of B-cell precursor ALL and results in the formation of the chimeric oncogenic transcription factor ETV6::RUNX1. OBJECTIVES: We aim to analyze factors promoting the generation of preleukemic ETV6::RUNX1 translocations, investigate the biological origin of these preleukemic cells, and develop an in vitro model of early B-cell differentiation to analyze the mechanisms underlying the persistence of ETV6::RUNX1+ preleukemic cells and leukemia evolution in children. METHODS: Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL) (Schafer et. al., 2018) was applied to identify ETV6::RUNX1+ cord blood units (CBU). Screening results were validated by Sanger sequencing and quantified by real-time PCR (ipsogen ETV6-RUNX1 Kit, Qiagen). ETV6::RUNX1+ CBUs were thawed, sorted for CD34(+) and CD19(+) cells, and analyzed by qPCR. CD34(+) were differentiated towards B-cell lineage on MSC feeder lines according to a modified protocol (Ichii et. al., 2008). RESULTS: We screened a cohort of 1405 cord bloods collected in 2004 and discovered that 103 (7.3%) carried the ETV6::RUNX1 fusion gene. The preleukemic translocation was detected in CD34(+) stem and early B progenitor cells. For the establishment of an in vitro B-cell differentiation model, bone marrow (BM-MSCs) and CB (USSCs, CB-MSCs) stromal feeder cells were compared and the effect of different media (SCGM, DMEM/5 % FCS, MSCBM/10 % FCS) in the presence of stem cell factor (SCF), Flt-3, IL3, +/- IL7 was assessed. BM-MSCs demonstrated the highest ability to support B-lymphopoieses towards CD19(+) cell differentiation in MSCBM media (~30%), primarily due to the release of IL-7 by the feeder layer. Currently, factors that may promote generation of preleukemic translocations in utero e.g. nitrosamines contained in food products, are being tested in this model. DISCUSSION: We identified the HSC/early B progenitor state as the origin of ETV6::RUNX1 translocations in CB. The establishment of an in vitro B-cell differentiation system will allow to test the impact of environmental carcinogens on the generation of ETV6::RUNX1+ pre-leukemic cells and their leukemic evolution. Oxford University Press 2023-09-04 /pmc/articles/PMC10476933/ http://dx.doi.org/10.1093/stcltm/szad047.025 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Preclinical Studies
Bhave, Rigveda
Kameri, Ersen
Körschgen, Lutz
Jepsen, Vera
Hecker, Katharina
Pandyra, Aleksandra
Borkhardt, Arndt
Fischer, Ute
Koegler, Gesine
Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells
title Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells
title_full Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells
title_fullStr Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells
title_full_unstemmed Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells
title_short Abstract 24 Development of an In Vitro B-Cell Differentiation Model for the Characterization of the Origin and Causation of ETV6::RUNX1+ Preleukemic Cells
title_sort abstract 24 development of an in vitro b-cell differentiation model for the characterization of the origin and causation of etv6::runx1+ preleukemic cells
topic Preclinical Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476933/
http://dx.doi.org/10.1093/stcltm/szad047.025
work_keys_str_mv AT bhaverigveda abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT kameriersen abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT korschgenlutz abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT jepsenvera abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT heckerkatharina abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT pandyraaleksandra abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT borkhardtarndt abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT fischerute abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells
AT koeglergesine abstract24developmentofaninvitrobcelldifferentiationmodelforthecharacterizationoftheoriginandcausationofetv6runx1preleukemiccells